Analyst consensus rating
Moderna Analyst Rating: Hold
MRNA is rated Hold by 18 analysts with a $112.56 target. As of 2026-09-02.
Direct answer
Moderna's consensus rating is Hold.
18 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $112.56.
Forecast evidence checked September 2, 2026.
Get free Moderna email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $147.67
- Average price target
- $112.56
- High price target
- $170.00
- Low price target
- $40.00
- Low target gap
- -72.9%
- Target upside
- -23.8%
- High target gap
- +15.1%
- Target range width
- 88%
- Consensus rating
- Hold
- Analysts
- 18
- Evidence date
- September 2, 2026
- Valid through
- September 9, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Moderna?
Moderna has a verified Hold consensus. The same dataset has an average price target of $112.56.
How far are Moderna's low and high targets from the recorded price?
The low target implies -72.9%, while the high target implies +15.1%.
How many analysts are included in Moderna's consensus?
The verified consensus includes 18 analysts.
How is Moderna's target upside or downside calculated?
The average target of $112.56 is divided by the recorded price of $147.67, then one is subtracted to produce -23.8%. This does not guarantee a future return.
When was Moderna's analyst forecast verified?
The data was verified on 2026-09-02. The dataset is valid through 2026-09-09.